Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Harvest Decision and Timing in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Harvest Decision and Timing in Bioreactor Operations – V 2.0


Standard Operating Procedure for Harvest Decision and Timing in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/086/2025
Supersedes SOP/BS/086/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a standardized procedure for determining the optimal time to harvest bioreactor cultures during biosimilar production, based on defined critical process parameters and quality attributes.

2. Scope

This SOP applies to all production-scale bioreactor operations in biosimilar manufacturing where mammalian or microbial cells are cultured for protein expression and product harvest.

3. Responsibilities

  • Production Technician: Monitor in-process parameters and notify the production lead when criteria for harvest are met.
  • Process Development Team: Define titer and viability thresholds in the Process Description.
  • QA Officer: Authorize harvest activity based on batch documentation and release of in-process results.

4. Accountability

The Production Manager is accountable for approving the harvest decision, ensuring all release criteria are met, and documenting the harvest initiation.

5. Procedure

5.1 Harvest Criteria Definition

  1. Define critical harvest criteria before batch execution in the BMR:
    • Cell viability (e.g., ≥80%)
    • Target titer (e.g., ≥1.5 g/L)
    • Metabolite profile (e.g., lactate ≤3 g/L, ammonia ≤1.5 mM)
    • Stability of pH and DO for ≥12 hours

5.2 Real-Time Monitoring

  1. Record daily values of:
    • Viability (Trypan Blue or flow cytometry)
    • Titer (protein assay)
    • Metabolites (glucose, lactate, ammonia)
  2. Plot viability and titer trends in Annexure-1.

5.3 Decision-Making Process

  1. When viability drops below the threshold and titer plateaus, notify the shift in-charge.
  2. Conduct final analysis for titer, pH, and viability.
  3. QA verifies:
    • All in-process testing is within specification
    • No pending deviations that could impact product quality
  4. Upon QA clearance, document harvest decision and record timestamp.

5.4 Harvest Timing Execution

  1. Schedule harvest within 2 hours of QA clearance.
  2. Stop feed additions, sparging, and agitation based on the defined process.
  3. Transfer harvest to hold tank or clarification system (refer SOP/BS/087/2025).

5.5 Documentation

  1. Record harvest decision, timestamp, and basis of decision in Harvest Decision Log (Annexure-2).
  2. Ensure authorized personnel sign the log prior to initiating harvest.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • DO: Dissolved Oxygen
  • g/L: Grams per Liter

7. Documents

  1. Harvest Criteria Trend Chart – Annexure-1
  2. Harvest Decision Log – Annexure-2

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 1025 Annex 2 – GMP for Biotech Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Harvest Criteria Trend Chart

Date Time Viability (%) Titer (g/L) pH Operator
04/05/2025 10:00 82 1.62 6.98 Rajesh Kumar

Annexure-2: Harvest Decision Log

Date Time Batch No. Harvest Authorized By Viability (%) Titer (g/L) Remarks
04/05/2025 11:15 BS-086-B04 QA Clearance 80 1.65 Meets threshold

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added titer trends and QA clearance requirement Process optimization and compliance
See also  Biosimilars: SOP for DO Cascade Settings in Bioreactor Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: API Manufacturing: SOP for Sample Tracking and Lab Numbering System – V 2.0
Next Post: BA-BE Studies: SOP for Incurred Sample Reanalysis (ISR) – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version